| scholarly article | Q13442814 |
| P50 | author | Douglas F. Nixon | Q44059330 |
| P2093 | author name string | Moore JP | |
| Markowitz MM | |||
| Binley JM | |||
| Hurley A | |||
| Ortiz GM | |||
| Schiller DS | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1249-1263 | |
| P577 | publication date | 2000-04-13 | |
| P1433 | published in | Journal of Infectious Diseases | Q4051141 |
| P1476 | title | The relationship between T cell proliferative responses and plasma viremia during treatment of human immunodeficiency virus type 1 infection with combination antiretroviral therapy | |
| P478 | volume | 181 |
| Q36223710 | Advances in understanding immunologic control of HIV infection |
| Q61928849 | Analysis of the proliferative responses to peptides in individuals with vigorous Gag protein-specific proliferation |
| Q35923352 | Antigen-presenting cell modulation induces a memory response to p24 in peripheral blood leukocytes from human immunodeficiency virus-infected individuals |
| Q35784804 | Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load |
| Q37422520 | Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides |
| Q36474240 | Diminished Proliferation of Human Immunodeficiency Virus-Specific CD4+T Cells Is Associated with Diminished Interleukin-2 (IL-2) Production and Is Recovered by Exogenous IL-2 |
| Q34470969 | Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection |
| Q34876018 | HIV-1 reservoirs |
| Q36371562 | HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity |
| Q33731771 | HIV-1-specific CD4+ T lymphocyte turnover and activation increase upon viral rebound |
| Q33950164 | High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation |
| Q34348075 | Human immunodeficiency virus-specific CD8(+) T-cell responses do not predict viral growth and clearance rates during structured intermittent antiretroviral therapy |
| Q34292622 | Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients |
| Q34876070 | Immune reconstitution |
| Q35923609 | Immunity to human immunodeficiency virus (HIV) in children with chronic HIV infection receiving highly active antiretroviral therapy |
| Q37374667 | Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells |
| Q47279066 | Similar HIV-1 evolution and immunological responses at 10 years despite several therapeutic strategies and host HLA Types |
| Q24536249 | Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection |
| Q43096910 | Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress human immunodeficiency virus type 1 (HIV-1) replication in HIV-1-infected CD4+ T cells and macrophages |
| Q34207580 | Structured treatment interruptions to control HIV-1 and limit drug exposure |
| Q74780517 | The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection |
| Q57089576 | Viremia control following antiretroviral treatment and therapeutic immunizationduring primary SIV251 infection of macaques |
Search more.